FDA Inspection
Daniel Fred Goodman, M.D.Daniel Fred Goodman, M.D. – FDA Inspection, Dec 13, 2021
Record Details
This FDA Inspection record concerns Daniel Fred Goodman, M.D., with an inspection on December 13, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Daniel Fred Goodman, M.D.
- Inspection Date
- December 13, 2021
- Product Type
- Drugs
View Company Profile
ID · 936fa295-a792-48b3-9102-1b99c535babc
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1159513
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
10- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.59Records of unused drug disposition
- 21 CFR 312.56(a)Monitoring investigations
- 21 CFR 312.60Informed consent
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.56(c)Annual report
- 21 CFR 50.27(a)Consent form not approved/signed/dated
- 21 CFR 50.25(a)(1)Procedures, identification of those which were experimental
- 21 CFR 50.25(c)ClincialTrials.gov statement
- 21 CFR 312.20(b)Starting a study before IND is in effect
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Daniel Fred Goodman, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 25, 2024 | NAI | San Francisco District Office | Bioresearch Monitoring: Human Drugs |
Other documents for Daniel Fred Goodman, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.